Clinical Trial

Liver Adiposity Effects on Pediatric Statin

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Single center, open-label, prospective investigation to quantify the effects hepatocellular fat has on hepatic statin transport and response in children and adolescents in obese and non-obese children and adolescents 8-21 years of age with normal, wild-type SLCO1B1 c.521TT genotype that are dosed rosuvastatin
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2021-05-22; most recent amendment 2026-06-23.
Trial Details
NCT Number NCT04903223
Lead Sponsor Children's Mercy Hospital Kansas City
Conditions Cholesterol; Lipidosis
Enrollment 50 participants
Start Date 2021-04-01
Primary Completion 2026-10-30 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-25